Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001133416-25-000008
Filing Date
2025-01-27
Accepted
2025-01-27 16:03:53
Documents
1
Period of Report
2025-01-23

Document Format Files

Seq Description Document Type Size
1 form4.html 4  
1 form4.xml 4 3703
  Complete submission text file 0001133416-25-000008.txt   5232
Mailing Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071
Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD SUITE 240 NORCROSS GA 30071 678-620-3186
GALECTIN THERAPEUTICS INC (Issuer) CIK: 0001133416 (see all company filings)

EIN.: 043562325 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 2121 RINGWOOD AVENUE SAN JOSE CA 95131
Business Address
ELDRED KARY (Reporting) CIK: 0001543425 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31791 | Film No.: 25558960